WO2012066485A3 - Agave fructans compositions and their use in mineral absorption - Google Patents

Agave fructans compositions and their use in mineral absorption Download PDF

Info

Publication number
WO2012066485A3
WO2012066485A3 PCT/IB2011/055113 IB2011055113W WO2012066485A3 WO 2012066485 A3 WO2012066485 A3 WO 2012066485A3 IB 2011055113 W IB2011055113 W IB 2011055113W WO 2012066485 A3 WO2012066485 A3 WO 2012066485A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
fructans
agave
agave fructans
inulin
Prior art date
Application number
PCT/IB2011/055113
Other languages
French (fr)
Other versions
WO2012066485A2 (en
Inventor
Mercedes Guadalupe LÓPEZ PÉREZ
María Isabel GARCÍA VIEYRA
Original Assignee
Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MX2010012605A external-priority patent/MX2010012605A/en
Priority claimed from MX2011007529A external-priority patent/MX369980B/en
Application filed by Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional filed Critical Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional
Publication of WO2012066485A2 publication Critical patent/WO2012066485A2/en
Publication of WO2012066485A3 publication Critical patent/WO2012066485A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to compositions comprising Agave fructans to stimulate the absorption of mineral salts and the fixation of bone in mammals, under osteoporosis condition, resulting in pronounced beneficial effects also in lowering plasma glucose levels and body weight reduction measured in ovariectomized mice, administering a standard diet and the compositions of the invention. The Agave fructans compositions of the invention have effects that outweigh inulin-type fructans known from other species, attributable mainly to the branched and non-linear structure of Agave fructans, as is the case with inulin.
PCT/IB2011/055113 2010-11-19 2011-11-16 Agave fructans compositions and their use in mineral absorption WO2012066485A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
MXMX/A/2010/0012605 2010-11-19
MX2010012605A MX2010012605A (en) 2010-11-19 2010-11-19 Agave fructans compositions and their use in mineral absorption.
MX2011007529A MX369980B (en) 2011-07-14 2011-07-14 Agave fructans compositions and their use in mineral absorption.
MXMX/A/2011/007529 2011-07-14

Publications (2)

Publication Number Publication Date
WO2012066485A2 WO2012066485A2 (en) 2012-05-24
WO2012066485A3 true WO2012066485A3 (en) 2012-09-07

Family

ID=45496214

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2011/055113 WO2012066485A2 (en) 2010-11-19 2011-11-16 Agave fructans compositions and their use in mineral absorption

Country Status (1)

Country Link
WO (1) WO2012066485A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7321503B2 (en) * 2019-05-21 2023-08-07 フジ日本精糖株式会社 Inulin-containing muscle mass decrease inhibitor or bone density decrease inhibitor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1125507A1 (en) * 2000-02-15 2001-08-22 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Inulin products with improved nutritional properties
JP2009254359A (en) * 2008-03-25 2009-11-05 Agabe:Kk Mineral absorption-promoting food, mineral-absorbable food, and method for promoting mineral absorption

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1125507A1 (en) * 2000-02-15 2001-08-22 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Inulin products with improved nutritional properties
JP2009254359A (en) * 2008-03-25 2009-11-05 Agabe:Kk Mineral absorption-promoting food, mineral-absorbable food, and method for promoting mineral absorption

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MERCEDES LOPEZ AND JUDITH URIAS SILVAS: "Agave fructans as prebiotics", RECENT ADVANCES IN FRUCTOOLIGOSACCHARIDES RESEARCH, 2007, pages 1 - 14, XP002676086, Retrieved from the Internet <URL:http://dfpcorec-p/wf/web/citenpl/citenpl.html?_url=http%3A%2F%2Fwww.iidea-korea.com%2Finfo%2Fthesis%2FAgave_Prebiotic.pdf> [retrieved on 20120516] *

Also Published As

Publication number Publication date
WO2012066485A2 (en) 2012-05-24

Similar Documents

Publication Publication Date Title
IN2012DN03632A (en)
BR112014015940A2 (en) composition of new carbohydrate drug to treat human diseases
MX337454B (en) Aqueous composition comprising bromhexine.
PH12015501309A1 (en) Human milk oligosaccharides to ameliorate symptoms of stress
IN2012DN00639A (en)
PH12014502698A1 (en) Improved antagonist antibodies against gdf-8 and uses therefor
WO2009152189A8 (en) Low dose topiramate/phentermine compostion and methods of use thereof
UA103915C2 (en) Solid dosage from comprising linagliptin and sglt2 inhibitor, and use thereof
MY160894A (en) Oligosaccharide composition for treating skin diseases
MX2015004644A (en) Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders.
BR112012028717A2 (en) personal care formulations containing alkyl ketal esters and manufacturing methods
IN2012DN02081A (en)
WO2011083150A3 (en) Obesity small molecules
MX2013005095A (en) Pharmaceutical composition, methods for treating and uses thereof.
MX2015013275A (en) Compositions comprising selenium and use of same for the treatment and prevention of disease or conditions associated with mitochondrial dysfunction.
IN2015DN01489A (en)
MX2011013032A (en) Inhibitors of phosphatidylinositol 3-kinase.
MX2009009154A (en) Spiro-pyrano-pyrazole derivatives.
EA032918B1 (en) Edible composition comprising resveratrol and flavonoid monoglucoside for reducing post-prandial blood gllucose peak amplitude or glycemic response
MX350463B (en) Methods of treating pain.
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
UA75461U (en) Medicine for the prevention of dental diseases
MX2011008645A (en) Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase.
BR112017005611A2 (en) Slowly digestible continuation type energy supplement
WO2012066485A3 (en) Agave fructans compositions and their use in mineral absorption

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11808939

Country of ref document: EP

Kind code of ref document: A2